Entegris

Entegris reported Q2 FY2026. EPS came in at $0.93 against a $0.82 consensus, beat by 13.1%. Revenue was $883.2M versus $835.8M expected, beat by 5.7%. Gross margin was 47.6%, up 640 bps from last quarter.

Entegris reported a solid Q1 FY2026, with revenue and EPS both exceeding street estimates. The company's strong free cash flow and disciplined capital management underscore its financial health, while the guidance for Q2 FY2026 indicates continued momentum.

Entegris printed only a modest revenue beat, but the market’s likely error is treating Q4 FY2025 as another slow materials quarter rather than the point where excess investment begins converting into lower CapEx, debt paydown capacity, and NAND-driven utilization. The variant view is that EPS quality matters less than the 2026 setup: management is telling investors it can support significantly more than $1 billion in incremental revenue with limited further investment while cutting 2026 CapEx to $250 million.

Entegris printed a revenue miss of -0.5% and EPS exactly in line, but the investable read is that the market is likely over-penalizing a stagnant top line while underpricing two more actionable facts: gross margin is being held back by utilization rather than pricing collapse, and cash generation is now large enough to accelerate balance-sheet repair. The variant view is that this quarter was not a demand inflection, but it did expose a cleaner setup: if wafer-start exposure stabilizes and utilization normalizes, earnings leverage can return before investors see a dramatic revenue breakout.

Entegris cleared a low bar on Q2 numbers, but the variant view is that the real asset in the print is not the $792.4 million revenue beat. The market is likely underpricing the manufacturing repositioning that can protect China and non-U.S. demand while margins stay capped by mix, cost, and leverage.